Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Michael Blume

Michael Blume, Gastroenterologist, Metropolitan Medical AssociatesGastroenterologist
Metropolitan Medical Associates
Member of the Healthcare Council

Michael Blume, MD, is a Gastroenterologist at the Metropolitan Medical Associates in Baltimore, Maryland. In addition to being in full-time private practice, he has extensive experience in utilization management and quality improvement. Dr. Blume has done consulting work for various clinical efficiency projects as well as lectured on this topic. He has served as Medical Staff President at the Good Samaritan Hospital in Baltimore and as the Medical Director of the Maryland Endoscopy Center in Towson. (This is me - Update Profile)


Employment History
1987 - present Gastroenterologist
Metropolitan Medical Associates
1983 - 1987 Gastroenterology
Private Practice

GLG NewsSM Analyses by Michael Blume(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
A relief, albeit a temporary one | 04-14-2008
Analysis of: Aetna to Delay Reduced Colonoscopy Coverage | online.wsj.com
Author: Michael Blume, Gastroenterologist, Metropolitan Medical Associates

This potential issue has been of concern since we changed to Propofol based anesthesia for all of our patients approximately five years ago.  We made this decision because it made endoscopic procedures significantly more tolerable (essentially painless, except for the bowel prep) for just...

Important data in a difficult to treat subpopulation | 12-17-2007
Author: Michael Blume, Gastroenterologist, Metropolitan Medical Associates

Patients with isolated proctitis remain a difficult to treat subpopulation of patients with UC.  Topical mesalamine is often efficacious, but is not always the preferred mode of administration for many patients.  As we have a variety of options as to which oral mesalamine preparation to use...

A small niche in the PPI market | 12-10-2007
Author: Michael Blume, Gastroenterologist, Metropolitan Medical Associates

Which PPI to prescribe?  We already have a myriad of choices between brands, which in general, are all quite effective when used for the correct indications.  An oral suspension is useful in a patient who requires PPI therapy, but who is unable to swallow pills for a variety of reasons. ...

Clinical data not surprising, cost data may be misleading...The question is when to use Remicade and in whom. | 10-29-2007
Author: Michael Blume, Gastroenterologist, Metropolitan Medical Associates

The clinical outcome information in this report regarding decreasing colectomy rate is not particularly surprising, but the cost statements may be misleading.  One wonders if the increased health care costs in the colectomy group reflect that fact that the observation period was only...

View All GLG News SM Analyses by Michael Blume

GLG InstituteSM Seminars with Michael Blume(?)

 
Michael Blume has not participated in any GLGi Seminars.
View all GLG InstituteSM Seminars in Healthcare

Request a project with Michael Blume









Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-09-06T17:45:17.377